QC
NVO

Quent Capital’s Novo Nordisk NVO Stock Holding History

Quent Capital’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.7K Sell
726
-144
-17% -$6.82K ﹤0.01% 904
2025
Q4 		$44.3K Buy
870
+144
+20% +$7.36K ﹤0.01% 778
2025
Q3 		$40.3K Buy
+726
New +$42.5K ﹤0.01% 663
2025
Q2 		– Sell
-726
Closed -$50.4K – 929
2025
Q1 		$50.4K Hold
726
– – 0.01% 559
2024
Q4 		$62.5K Buy
+726
New +$78.5K 0.01% 529

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Quent Capital's NVO Position: Q1 2026 in Review

Quent Capital reduced its Novo Nordisk (NVO) stake by 17% in Q1 2026, selling an estimated $6.82K and leaving 726 shares worth $26.7K. The position accounts for ﹤0.01% of the portfolio, ranked #904.

Quent Capital first reported a position in NVO in Q4 2024 and has held it in 5 quarters since. The position peaked at $62.5K in Q4 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • Quent Capital held 726 shares of Novo Nordisk worth $26.7K as of Q1 2026.
  • Quent Capital sold 144 Novo Nordisk shares in Q1 2026, an estimated $6.82K.
  • Novo Nordisk made up ﹤0.01% of Quent Capital's portfolio in Q1 2026, its #904 holding.
  • Quent Capital first reported a position in Novo Nordisk in Q4 2024 and has held it in 5 quarters since.
  • Quent Capital's Novo Nordisk position peaked at $62.5K in Q4 2024.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Quent Capital's 13F filing for Q1 2026, filed 28 Apr 2026.